Stockreport

Sosei Heptares Notes That a Valid Marketing Authorization Application For QVM149, a Potential New Inhaled Combination Therapy For Asthma, Has Been Filed With the European Medicines Agency

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF TOKYO and LONDON, May 23, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) announces it has been notified today by its strategic alliance partner [Read more]